Basic Information
Beech Biotech is a developer of monoclonal antibodies aimed at providing treatment options for pregnant women. The company specializes in researching, developing, and producing monoclonal antibodies that target maternal health conditions without affecting the unborn child, enabling healthcare professionals to offer treatments that support prolonging pregnancy and reducing risks associated with preterm birth and pregnancy complications.
Beech Biotech SA
Lausanne,Vaud,Switzerland
15~50 people
January 01, 2022
--

